BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Aug 9, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-08-08

Reporting Person: Stonehouse Jon P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-08	Common Stock	P	10000	$2.519	Acquired	217492	Direct

Footnotes

F1: The price in column 4 is a weighted average price. The prices actually ranged from $2.50 to $2.52. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

F2: Includes 1,672 shares asquired under the Company's Employee Stock Purchase Plan on July 29, 2011